Healthcare & Life Sciences
Adoram Therapeutics
Switzerland
pre-seed
pre-seed
Stage
1
Investors
About
Adoram Therapeutics is a biopharmaceutical company developing therapeutic candidates that leverage allosteric biochemistry to address disease pathways in pharma and biotech sectors.
Explore Adoram Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.